What have Congress and the FDA done in response?

MPPA 582-01, Healthcare Policy, Winter 2017_rev 30Dec2016 mg Page 13increased dramatically in the last decade, nearly tripling. In especially short supply is a generic version of an important cancer drug. What is the threat to public health? What’s wrong with the drug production and distribution system? What have Congress and the FDA done in response? How can private enterprise and government agencies address this problem?15. Health Care and the poor: Community health providers who treat the poor find they cycle in and out of care due to periods of homelessness, jail time, and other barriers, disrupting medical regimens. What are implications for individual health and public health? What provisions of the ACA can help address these issues?Proposing an Alternative TopicIf you prefer to work on a topic not listed above, you must submit a proposal (typewritten, single-spaced, due no later than our first class meeting) addressing each of these points and arguing why your topic is relevant to health care policymaking as well as recent health care reforms:(1) state your key policy question (examples provided above);(2) state what level of governance is involved at which a policy decision should be made(local, state, federal; specific agency), and provide the rationale for why that governmentalentity is critical for this issue;(3) identify 2 key positions on this issue, including how each identifies the problem and whateach proposes for a solution; for example, using a topic above, DTC advertising of pharmaceuticals is argued by some as improving patient choice and by others as inventing demand – what is each side identifying as a problem, and what do they suggest be done about it?(4) outline sources of evidence each position puts forth in its claims; and,(5) finally, looking at the topic areas for each week of this course, consider which you expect tobe most relevant for your topic and why; for example, DTC advertising of prescription drugs is relevant to the study of the patient empowerment movement as well as the study of medical industries and the role of profit-making in health-related fields.